Ex Parte No Data - Page 23

                Appeal 2007-2783                                                                             
                Reexamination 90/005,509                                                                     
                Patent 5,533,499                                                                             
                      that CNS, Inc. received orders during December, 1994                                   
                      substantially exceeding one million units for its product,                             
                      that CNS, Inc. received orders during January, 1995                                    
                      substantially in excess of six million units of the product, and                       
                      that the product sold as mentioned in his previous declaration as                      
                      well as the current declaration comes within the scope of one                          
                      or more of the pending claims in the above-identified                                  
                      application which have been rejected during the                                        
                      prosecution thereof, such rejection being the action from                              
                      which this appeal has been taken.  [Emphasis added.]                                   
                      The “appeal” mentioned in Mr. Cohen’s declaration dated February                       
                13, 1995, is not the current appeal, as that declaration was executed on                     
                February 13, 1995, a date even prior to original issuance of the patent                      
                undergoing reexamination in this case, which reexamination proceeding                        
                resulted in the current appeal.                                                              
                      It is well established that when it comes to objective evidence of                     
                nonobviousness, “[a] nexus is required between the merits of the claimed                     
                invention and the evidence offered, if that evidence is to be given substantial              
                weight enroute to conclusion on the obviousness issue.” Stratoflex, Inc. v.                  
                Aeroquip Corp., 713 F.2d at 1539, 218 USPQ at 879.  See also In re Fielder,                  
                471 F.2d 640, 642, 176 USPQ 300, 302 (1973).  Commercial success is                          
                relevant only if it flows from the merits of the invention claimed.  Sjolund v.              
                Musland, 847 F.2d at 1582, 6 USPQ2d at 2028.  More specifically, as was                      

                                                     23                                                      

Page:  Previous  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  Next

Last modified: September 9, 2013